Coupang, Inc.

NYSE:CPNG

23.37 (USD) • At close April 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 7,9657,8667,3237,1146,5616,183.5555,837.8895,800.535,326.7745,101.3345,037.8215,116.6865,076.6934,644.7054,478.1144,206.863,803.4933,136.5072,614.082,413.259
Cost of Revenue 5,4745,5975,1815,1854,8814,617.7684,314.1014,380.6034,047.9883,867.4463,884.0284,073.284,271.0923,890.1783,819.623,474.3543,154.2982,669.5522,174.3451,982.964
Gross Profit 2,4912,2692,1421,9291,6801,565.7871,523.7881,419.9271,278.7861,233.8881,153.7931,043.406805.601754.527658.494732.506649.195466.955439.735430.295
Gross Profit Ratio 0.3130.2880.2930.2710.2560.2530.2610.2450.240.2420.2290.2040.1590.1620.1470.1740.1710.1490.1680.178
Reseach & Development Expenses 00000000000000000000
General & Administrative Expenses 2,1792,1602,1671,8891,5501,478.3031,376.1461,313.1521,195.3771,156.4681,220.9361,249.1111,202.1991,069.6391,173.43999.822791.835683.192534.953503.932
Selling & Marketing Expenses 00000000000000000000
SG&A 2,1792,1602,1671,8891,549.3991,478.3031,376.1461,313.1521,195.3771,156.4681,220.9361,249.1111,202.1991,069.6391,173.43999.822791.835683.192534.953503.932
Other Expenses 000-90.556-7.776-5.241-6.539-9.211.224-9.2290.49-3.434-4.0260.373-3.826067.70416.366-10.241
Operating Expenses 2,1792,1602,1671,8891,5501,478.3031,376.1461,313.1521,195.3771,156.4681,220.9361,249.1111,202.1991,069.6391,173.43999.822791.835683.192534.953503.932
Operating Income 312109-254013087.484147.642106.77583.409104.047-67.143-205.705-396.598-315.112-514.936-267.316-142.64-216.237-95.218-73.637
Operating Income Ratio 0.0390.014-0.0030.0060.020.0140.0250.0180.0160.02-0.013-0.04-0.078-0.068-0.115-0.064-0.038-0.069-0.036-0.031
Total Other Income Expenses Net -332328194129.16623.57617.04410.12420.142-8.008-3.344-7.55-8.799-3.568-27.70948.21143.259-6.748-31.593
Income Before Tax 279132359171116.65171.218123.81993.53397.562-75.151-209.049-404.148-323.911-518.504-295.025-94.429-172.978-101.966-105.23
Income Before Tax Ratio 0.0350.01700.0080.0260.0190.0290.0210.0180.019-0.015-0.041-0.08-0.07-0.116-0.07-0.025-0.055-0.039-0.044
Income Tax Expense 1486810883-86125.3526.02632.964-8.5316.8830.340.2450.8310.0660.0970.0080.0640.0210.0840.123
Net Income 15670-7751,032.65391.314591102.06490.679-75.491-209.294-404.979-323.977-518.601-295.033-94.493-172.999-102.05-105.353
Net Income Ratio 0.020.009-0.0110.0010.1570.0150.0250.0160.0190.018-0.015-0.041-0.08-0.07-0.116-0.07-0.025-0.055-0.039-0.044
EPS 0.0870.039-0.040.0030.580.0510.0820.0510.0580.051-0.043-0.12-0.23-0.19-0.3-0.68-0.059-0.11-0.064-0.066
EPS Diluted 0.0850.038-0.040.0030.570.0510.0810.0510.0570.051-0.043-0.12-0.23-0.19-0.3-0.68-0.059-0.11-0.064-0.066
EBITDA 439280146193207154.877293.635254.534235.945234.118-6.744-142.441-341.223-264.995-465.714-222.818-23.122-114.97-47.927-53.303
EBITDA Ratio 0.0550.0360.020.0270.0320.0250.050.0440.0440.046-0.001-0.028-0.067-0.057-0.104-0.053-0.006-0.037-0.018-0.022